Jpmorgan Chase & CO Sc Pharmaceuticals Inc. Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 28,745 shares of SCPH stock, worth $162,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,745

Previous 28,745 -0.0%

Holding current value

$162,984

Previous $162,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$3.86 - $5.84 $24,534 - $37,119	6,356 Added 28.39%	28,745 $162,000
Q1 2025 May 12, 2025	SELL	$2.63 - $3.68 $164,211 - $229,771	-62,438 Reduced 73.61%	22,389 $58,000
Q4 2024 Feb 12, 2025	BUY	$3.14 - $4.53 $227,602 - $328,357	72,485 Added 587.3%	84,827 $300,000
Q3 2024 Dec 26, 2024	SELL	$4.12 - $5.51 $1,829 - $2,446	-444 Reduced 3.47%	12,342 $56,000
Q3 2024 Nov 08, 2024	SELL	$4.12 - $5.51 $1,829 - $2,446	-444 Reduced 3.47%	12,342 $56,000

Q2 2024 Dec 26, 2024	BUY	$3.51 - $5.21 $1,558 - $2,313	444 Added 3.6%	12,786 $55,000
Q2 2024 Aug 12, 2024	BUY	$3.51 - $5.21 $2,727 - $4,048	777 Added 6.47%	12,786 $55,000
Q1 2024 Dec 26, 2024	SELL	$4.86 - $6.39 $1,618 - $2,127	-333 Reduced 2.7%	12,009 $60,000
Q1 2024 May 10, 2024	SELL	$4.86 - $6.39 $36,887 - $48,500	-7,590 Reduced 38.73%	12,009 $60,000
Q4 2023 Dec 26, 2024	BUY	$4.7 - $6.63 $34,107 - $48,113	7,257 Added 58.8%	19,599 $122,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $9.82 $19,544 - $27,417	-2,792 Reduced 12.47%	19,599 $139,000
Q2 2023 Aug 11, 2023	BUY	$8.94 - $11.74 $31,710 - $41,641	3,547 Added 18.82%	22,391 $228,000
Q1 2023 May 11, 2023	SELL	$5.59 - $9.47 $188,595 - $319,498	-33,738 Reduced 64.16%	18,844 $170,000
Q4 2022 Feb 13, 2023	BUY	$4.02 - $7.53 $211,379 - $395,942	52,582 New	52,582 $377,000
Q1 2022 May 11, 2022	SELL	$3.9 - $6.11 $54 - $85	-14 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$3.88 - $6.9 $54 - $96	14 New	14 $0

Others Institutions Holding SCPH

# of Institutions

117

Shares Held

38.3M

Call Options Held

835K

Put Options Held

173K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $155M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Sc Pharmaceuticals Inc. Transaction History